NCT02096263 · Interventional trial
Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants
Overall registry status Completed
Phase 3
Conditions Acellular Pertussis, Diphtheria, Haemophilus Influenzae Type b, Hepatitis B, Poliomyelitis, Tetanus
Delaware Valley sites
- GSK Investigational Site · Sellersville, PA · Bucks County
First posted
Registry updated
Added to the directory